Healthspan Economy

The Atlas / Regulations

Rules that apply to clinics and products

One record for each instrument in each market. Every record links to the regulator's own text and shows the date the Atlas read it. A record marked Checked was read in its primary source; a record marked WATCH is an instrument that is pending or unsettled, with what is known. The Atlas states what an instrument says and does not give legal advice. 23 records across 18 markets, 2 of them on watch.

Asia1

ASEAN Medical Device Directive

Sets common essential principles and risk classification rules for medical devices, and enters into force only among member states that have accepted it under their own domestic requirements.

ASEAN Secretariat Product Read November 14, 2026
Checked

Canada1

Canada Health Act, sections 18 and 19, extra-billing and user charges

Defines extra-billing as billing for an insured health service above what a provincial health care insurance plan pays, and the Act's sections 18 and 19 deal with extra-billing and user charges.

Parliament of Canada Other Read November 14, 2026
Checked

Denmark1

Hospital exemption under Article 28 of Regulation (EC) No 1394/2007

Defines the hospital exemption as an advanced therapy medicinal product prepared on a non-routine basis and used in a hospital in the same Member State under a medical practitioner's responsibility for an individual patient.

Danish Medicines Agency (Laegemiddelstyrelsen) Product Read November 14, 2026
Checked

Germany1

Section 4b Arzneimittelgesetz (German Medicines Act), non-routinely produced advanced therapy medicinal products

Names the Paul-Ehrlich-Institut as the authority that authorises non-routinely manufactured advanced therapy medicinal products under section 4b (3) of the German Medicines Act.

Paul-Ehrlich-Institut Product Read November 14, 2026
Checked

Hong Kong SAR1

Private Healthcare Facilities Ordinance (Cap. 633), clinic licence and small practice exemption

Clinics operating on 30 November 2018 could apply for a provisional clinic licence between 13 October 2025 and 13 April 2026.

Office for Regulation of Private Healthcare Facilities, Department of Health Premises Read November 14, 2026
Checked

Italy2

Decree of 16 January 2015 on advanced therapy medicinal products prepared on a non-repetitive basis

Sets provisions for advanced therapy medicinal products prepared on a non-repetitive basis, as its title states.

Ministero della Salute Product Read November 14, 2026
Checked

Legislative Decree 502/1992, article 8-ter, authorization of healthcare facilities

Requires an authorization to build a healthcare structure and a separate authorization to operate it, and has the regions set the procedures and terms for requesting them.

Italian Parliament (Normattiva) Premises Read November 14, 2026
Checked

Japan3

Act No. 51 of 2024, amendment of the Act on the Safety of Regenerative Medicine and the Clinical Trials Act

The notice says the amending Act was promulgated on 14 June 2024 to be enforced in stages, and extends the safety law to gene therapy that does not use processed cells.

Ministry of Health, Labour and Welfare Product Read November 14, 2026
WATCH

Act on the Safety of Regenerative Medicine

Requires a provision plan for regenerative medicine to be submitted and reviewed by a certified committee, and sets rules for manufacturing cells for it.

Ministry of Health, Labour and Welfare (Japanese Law Translation) Product Read November 14, 2026
Checked

Medical Care Act, Article 8, notification to open a clinic

Requires a clinically trained physician, dentist or midwife who establishes a clinic or birthing center to notify the prefectural governor within ten days of its establishment.

Ministry of Health, Labour and Welfare (Japanese Law Translation) Premises Read November 14, 2026
Checked

Middle East1

GCC centralized registration, Resolution No. 6 of the 45th conference

Runs a central registration of medicines for the member states, approved by Resolution No. 6 of the council's forty-fifth conference held in Geneva in May 1998.

Gulf Health Council Product Read November 14, 2026
Checked

Saudi Arabia2

Guideline on Classification of Advanced Therapy Medicinal Products, Version 1.0

Gives the Saudi Food and Drug Authority's classification of advanced therapy medicinal products, issued 6 November 2023.

Saudi Food and Drug Authority Product Read November 14, 2026
Checked

Healthcare Investor Licensing Guide

Guides investors through licensing healthcare facilities, from hospitals to laboratories; the guide names no longevity facility type.

Ministry of Health Saudi Arabia Premises Read November 14, 2026
Checked

Singapore1

List of specified services under the Healthcare Services Act

Lists each licensable healthcare service, such as the Outpatient Medical Service, with the modes of service delivery allowed for it; the list names no longevity service.

Ministry of Health Singapore (Healthcare Services Act, HCSA) Premises Read November 14, 2026
Checked

South Korea2

Bioethics and Safety Act

Defines genetic testing as analyzing chromosomes or genes from samples such as blood, hair or saliva to identify a person or test for a disease or predisposition, and regulates genetic testing and genetic data.

Ministry of Health and Welfare (Korea Legislation Research Institute translation) Laboratory Read November 14, 2026
Checked

Medical Service Act

Is the Act that governs medical institutions in Korea, including clinics and hospitals.

Ministry of Health and Welfare (Korea Legislation Research Institute translation) Premises Read November 14, 2026
Checked

Sweden1

Patient Safety Act (patientsakerhetslagen), duty to notify new or changed healthcare services

A provider that intends to start a service under IVO supervision must notify IVO at least one month before it starts, and report a change or closure within one month.

Inspektionen for vard och omsorg (IVO) Premises Read November 14, 2026
Checked

Switzerland1

Legal basis governing the use of tissues and cells of human origin (Therapeutic Products Act and Transplantation Act)

Says use of human tissues and cells is subject to principles and restrictions under the Transplantation Act and the Therapeutic Products Act, and that a Swissmedic establishment licence or authorisation may be needed.

Swissmedic Product Read November 14, 2026
Checked

United Arab Emirates2

Healthy Longevity Medicine Clinic Standard

Sets the minimum requirements for healthy longevity medicine clinic services in the Emirate of Abu Dhabi, for facilities licensed by the Department of Health to provide them.

Department of Health Abu Dhabi Premises Read November 14, 2026
Checked

Standards for Stem Cells and Regenerative Medicine

Sets the standards for stem cell and regenerative medicine services, issued 20 February 2025 by the Health Regulation Sector.

Dubai Health Authority Product Read November 14, 2026
Checked

United Kingdom1

Guidance on the UK hospital exemption scheme for advanced therapy medicinal products (Human Medicines Regulation 2012)

Explains the arrangements for advanced therapy medicinal products made and used under the hospital exemption scheme in the UK, and says the guidance does not cover products authorised by marketing authorisation or supplied for a clinical trial.

Medicines and Healthcare products Regulatory Agency Product Read November 14, 2026
Checked

United States1

Laboratory developed tests: May 2024 final rule vacated, text reverted

The FDA's page says its 6 May 2024 final rule on laboratory developed tests was vacated by a federal district court on 31 March 2025 and that on 19 September 2025 it issued a final rule reverting the regulation to its earlier text.

Food and Drug Administration Laboratory Read November 14, 2026
WATCH

Vietnam1

Law on Medical Examination and Treatment

Requires practice competence assessment for physicians from 1 January 2027, for nurses, midwives and medical assistants from 1 January 2028, and for other titles from 1 January 2029.

National Assembly of Viet Nam Premises Read November 14, 2026
Checked